A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Clinical trial NCT06760546 · RECRUITING

Trial details

NCT number: NCT06760546
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypothalamic Obesity Multiple Pituitary Hormone Deficiency Genetic Form Septo-Optic Dysplasia Optic Nerve Hypoplasia Childhood-onset Combined Pituitary Hormone Deficiency Pituitary Stalk Interruption Syndrome

Start date: 2025-09-23
Primary completion: 2027-03-13
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.